Physician profile
Scott A Mckee
NPI 1700903465
$3,034.95
in general payments reported to CMS, 2019-2025
25 companies · $476 in 2025
The $476 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $913 · 2020: $94.37 · 2021: $271 · 2022: $172 · 2023: $304 · 2024: $804 · 2025: $476.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,567 · Education: $17.26.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,567.35 |
| Education | $17.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $371.66 | 2019-2025 | |
| Medtronic, INC. | $305.32 | 2019-2024 | Symplicity G3, Onyx Frontier |
| Medtronic Vascular, INC. | $292.39 | 2019-2020 | |
| Boston Scientific Corporation | $272.95 | 2019-2024 | Avvigo Guidance System |
| Pfizer INC. | $250.73 | 2022-2025 | |
| Abiomed | $207.47 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $182.95 | 2019-2025 | Lifevest |
| W. L. Gore & Associates, INC. | $180.03 | 2020-2021 | |
| Abbott Laboratories | $144.64 | 2024-2025 | Xience Skypoint |
| Amgen INC. | $136.87 | 2020-2025 | Repatha |
| Shockwave Medical, INC | $136.10 | 2021-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Novo Nordisk INC | $111.56 | 2023-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $76.16 | 2019-2025 | Wainua |
| Janssen Pharmaceuticals, INC | $66.72 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $51.80 | 2019-2025 | Camzyos |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Siemens Medical Solutions USA, INC. | $49.69 | 2024 | Naeotom Alpha, Magnetom Sola |
| Edwards Lifesciences Corporation | $42.70 | 2024 | Hemosphere |
| Esperion Therapeutics, INC. | $37.80 | 2023-2024 | Nexletol |
| Cardiva Medical, INC. | $23.42 | 2024 | Cardiva Vascade Mvp Vvcs 6-12f |
| Amarin Pharma, INC. | $20.18 | 2019 | |
| Philips North America LLC | $19.30 | 2021 | |
| United Therapeutics Corporation | $19.14 | 2020 | |
| Inari Medical, INC. | $18.43 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Cordis US Corp. | $16.24 | 2024 | Mynx Control |
| Cardiovascular Systems INC. | $0.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Mckee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.